Literature DB >> 26045304

Analysis of the genetic architecture of susceptibility to cervical cancer indicates that common SNPs explain a large proportion of the heritability.

Dan Chen1, Tao Cui2, Weronica E Ek2, Han Liu3, Huibo Wang4, Ulf Gyllensten2.   

Abstract

The genetic architecture of susceptibility to cervical cancer is not well-understood. By using a genome-wide association study (GWAS) of 1034 cervical cancer patients and 3948 controls with 632668 single-nucleotide polymorphisms (SNPs), we estimated that 24.0% [standard error (SE) = 5.9%, P = 3.19×10(-6)] of variation in liability to cervical cancer is captured by autosomal SNPs, a bit lower than the heritability estimated from family study (27.0%), suggesting that a substantial proportion of the heritability is tagged by common SNPs. The remaining missing heritability most probably reflects incomplete linkage disequilibrium between causal variants and the genotyped SNPs. The variance explained by each chromosome is not related to its length (R (2) = 0.020, P = 0.516). Published genome-wide significant variants only explain 2.1% (SE = 1.5%, P = 0) of phenotypic variance, which reveals that most of the heritability has not been detected, presumably due to small individual effects. Another 2.1% (SE = 1.1%, P = 0.013) of variation is attributable to biological pathways associated with risk of cervical cancer, supporting that pathway analysis can identify part of the hidden heritability. Except for human leukocyte antigen genes and MHC class I polypeptide-related sequence A (MICA), none of the 82 candidate genes/regions reported in other association studies contributes to the heritability of cervical cancer in our dataset. This study shows that risk of cervical cancer is influenced by many common germline genetic variants of small effects. The findings are important for further study design to identify the hiding heritability that has not yet been revealed. More susceptibility loci are yet to be found in GWASs with higher power.
© The Author 2015. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Year:  2015        PMID: 26045304     DOI: 10.1093/carcin/bgv083

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  9 in total

Review 1.  Epigenome-based cancer risk prediction: rationale, opportunities and challenges.

Authors:  Martin Widschwendter; Allison Jones; Iona Evans; Daniel Reisel; Joakim Dillner; Karin Sundström; Ewout W Steyerberg; Yvonne Vergouwe; Odette Wegwarth; Felix G Rebitschek; Uwe Siebert; Gaby Sroczynski; Inez D de Beaufort; Ineke Bolt; David Cibula; Michal Zikan; Line Bjørge; Nicoletta Colombo; Nadia Harbeck; Frank Dudbridge; Anne-Marie Tasse; Bartha M Knoppers; Yann Joly; Andrew E Teschendorff; Nora Pashayan
Journal:  Nat Rev Clin Oncol       Date:  2018-02-27       Impact factor: 66.675

2.  The association of telomere maintenance and TERT expression with susceptibility to human papillomavirus infection in cervical epithelium.

Authors:  Li-Na Wang; Li Wang; Guanghui Cheng; Mingkai Dai; Yunhai Yu; Guoxin Teng; Jingjie Zhao; Dawei Xu
Journal:  Cell Mol Life Sci       Date:  2022-01-31       Impact factor: 9.261

3.  Estimation of heritability for nine common cancers using data from genome-wide association studies in Chinese population.

Authors:  Juncheng Dai; Wei Shen; Wanqing Wen; Jiang Chang; Tongmin Wang; Haitao Chen; Guangfu Jin; Hongxia Ma; Chen Wu; Lian Li; Fengju Song; YiXin Zeng; Yue Jiang; Jiaping Chen; Cheng Wang; Meng Zhu; Wen Zhou; Jiangbo Du; Yongbing Xiang; Xiao-Ou Shu; Zhibin Hu; Weiping Zhou; Kexin Chen; Jianfeng Xu; Weihua Jia; Dongxin Lin; Wei Zheng; Hongbing Shen
Journal:  Int J Cancer       Date:  2016-10-11       Impact factor: 7.396

4.  Combined analysis of pri-miR-34b/c rs4938723 and TP53 Arg72Pro with cervical cancer risk.

Authors:  Fang Yuan; Ruifen Sun; Peng Chen; Yundan Liang; Shanshan Ni; Yi Quan; Juan Huang; Lin Zhang; Linbo Gao
Journal:  Tumour Biol       Date:  2015-11-30

Review 5.  Impact of the MICA-129Met/Val Dimorphism on NKG2D-Mediated Biological Functions and Disease Risks.

Authors:  Antje Isernhagen; Dörthe Malzahn; Heike Bickeböller; Ralf Dressel
Journal:  Front Immunol       Date:  2016-12-12       Impact factor: 7.561

Review 6.  Genetic susceptibility to cervical neoplasia.

Authors:  Matthew A Brown; Paul J Leo
Journal:  Papillomavirus Res       Date:  2019-04-05

7.  Genome-wide association study and functional follow-up identify 14q12 as a candidate risk locus for cervical cancer.

Authors:  Dhanya Ramachandran; Joe Dennis; Laura Fachal; Peter Schürmann; Kristine Bousset; Fabienne Hülse; Qianqian Mao; Yingying Wang; Matthias Jentschke; Gerd Böhmer; Hans-Georg Strauß; Christine Hirchenhain; Monika Schmidmayr; Florian Müller; Ingo Runnebaum; Alexander Hein; Frederik Stübs; Martin Koch; Matthias Ruebner; Matthias W Beckmann; Peter A Fasching; Alexander Luyten; Matthias Dürst; Peter Hillemanns; Douglas F Easton; Thilo Dörk
Journal:  Hum Mol Genet       Date:  2022-08-17       Impact factor: 5.121

8.  Leveraging Methylation Alterations to Discover Potential Causal Genes Associated With the Survival Risk of Cervical Cancer in TCGA Through a Two-Stage Inference Approach.

Authors:  Jinhui Zhang; Haojie Lu; Shuo Zhang; Ting Wang; Huashuo Zhao; Fengjun Guan; Ping Zeng
Journal:  Front Genet       Date:  2021-06-02       Impact factor: 4.599

9.  Association of homozygous variants of STING1 with outcome in human cervical cancer.

Authors:  Joyce M Lubbers; Bart Koopman; Jessica M de Klerk-Sluis; Nienke van Rooij; Annechien Plat; Harry Pijper; Timco Koopman; Bettien M van Hemel; Harry Hollema; Bea Wisman; Hans W Nijman; Marco de Bruyn
Journal:  Cancer Sci       Date:  2020-11-20       Impact factor: 6.518

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.